Multi-center trial on the early effects of silodosin on lower urinary tract symptoms associated with benign prostatic hyperplasia
Silodosin (URIEF), a new so-called 3rd generation alpha-1 blocker, is widely expected to be effective and useful for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), due to its high specificity to alpha-1A receptor. We evaluated the efficacy of Silodosin, on 18...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 54(2008), 12 vom: 22. Dez., Seite 757-64 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
2008
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | English Abstract Journal Article Multicenter Study Adrenergic alpha-Antagonists Indoles silodosin CUZ39LUY82 |